Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency

Go back to Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.38 -0.01 (2.56%)
Previous Close $0.39    52 Week High $4.35 
Open $0.39    52 Week Low $0.44 
Day High $0.40    P/E N/A 
Day Low $0.38    EPS $-0.81 
Volume 516,739